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Abstract
Background: Bovine leukemia virus (BLV) is closely related to human T-cell leukemia virus (HTLV) and is the
etiological agent of enzootic bovine leukosis, a disease characterized by a highly extended course that often
involves persistent lymphocytosis and culminates in B-cell lymphomas. BLV provirus remains integrated in cellular
genomes, even in the absence of detectable BLV antibodies. Therefore, to understand the mechanism of BLV-
induced leukemogenesis and carry out the selection of BLV-infected animals, a detailed evaluation of changes in
proviral load throughout the course of disease in BLV-infected cattle is required. The aim of this study was to
develop a new quantitative real-time polymerase chain reaction (PCR) method using Coordination of Common
Motifs (CoCoMo) primers to measure the proviral load of known and novel BLV variants in clinical animals.
Results: Degenerate primers were designed from 52 individual BLV long terminal repeat (LTR) sequences identified
from 356 BLV sequences in GenBank using the CoCoMo algorithm, which has been developed specifically for the
detection of multiple virus species. Among 72 primer sets from 49 candidate primers, the most specific primer set
was selected for detection of BLV LTR by melting curve analysis after real-time PCR amplification. An internal BLV
TaqMan probe was used to enhance the specificity and sensitivity of the assay, and a parallel amplification of a
single-copy host gene (the bovine leukocyte antigen DRA gene) was used to normalize genomic DNA. The assay is
highly specific, sensitive, quantitative and reproducible, and was able to detect BLV in a number of samples that
were negative using the previously developed nested PCR assay. The assay was also highly effective in detecting
BLV in cattle from a range of international locations. Finally, this assay enabled us to demonstrate that proviral load
correlates not only with BLV infection capacity as assessed by syncytium formation, but also with BLV disease
progression.
Conclusions: Using our newly developed BLV-CoCoMo-qPCR assay, we were able to detect a wide range of
mutated BLV viruses. CoCoMo algorithm may be a useful tool to design degenerate primers for quantification of
proviral load for other retroviruses including HTLV and human immunodeficiency virus type 1.
Background
Many viruses mutate during evolution, which can lead
to alterations in pathogenicity and epidemic outbreaks
[1,2]. The development of molecular techniques, espe-
cially those applications based on the polymerase chain
reaction (PCR), has revolutionized the diagnosis of viral
infectious diseases [3,4]. Degenerate oligonucleotide pri-
mers, which allow the amplification of several possible
mutated versions of a gene, have been successfully used
for cDNA cloning and for the detection of sequences
t h a ta r eh i g h l yv a r i a b l ed u et oah i g hr a t eo fm u t a t i o n
[5]. Degenerate primers are useful for the amplification
of unknown genes, and also for the simultaneous ampli-
fication of similar, but not identical, genes [6]. The use
of degenerate primers can significantly reduce the cost
and time spent on viral detection. The “Coordination of
Common Motifs” (CoCoMo) algorithm has been devel-
oped especially for the detection of multiple virus spe-
cies (Endoh D, Mizutani T, Morikawa S, Hamaguchi I,
Sakai K, Takizawa K, Osa Y, Asakawa M, Kon Y,
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This program uses an extension of the COnsensus-
DEgenerate Hybrid Oligonucleotide Primer (CodeHop)
technique [7], which is based on multiple DNA
sequence alignments using MAFFT multiple sequence
alignment program [8]. The CoCoMo selects common
gap tetranucleotide motifs (GTNM), which include
codons from the target sequences. It then selects ampli-
fiable sets of common GTNMs using a database-based
method and constructs consensus oligonucleotides at
the 5’ end of each common amplifiable GTNM. The
consensus degenerate sequence is then attached to the
designed degenerate primers. Thus, the CoCoMo algo-
rithm is very useful in the design of degenerate primers
for highly degenerate sequences.
Bovine leukemia virus (BLV) is closely related to
human T-cell leukemia virus types 1 and 2 (HTLV-1
and -2) and is the etiological agent of enzootic bovine
leukosis (EBL), which is the most common neoplastic
disease of cattle [9]. Infection with BLV can remain
clinically silent, with cattle in an aleukemic state. It can
also emerge as a persistent lymphocytosis (PL), charac-
terized by an increased number of B lymphocytes, or
more rarely, as a B-cell lymphoma in various lymph
nodes after a long latent period [9].
In addition to the structural and enzymatic Gag, Pol,
and Env proteins, BLV encodes at least two regulatory
proteins, namely Tax and Rex, in the pX region located
between the env gene and the 3’ long terminal repeat
(LTR) [9]. Moreover, BLV contains several other small
open reading frames in the region between the env gene
and the tax/rex genes in the pX region. These encode
products designated as R3 and G4 [10]. BLV has two
identical LTRs, which possess a U3 region, an unusually
long R region, and a U5 region; these LTRs only exert
efficient transcriptional promoter activity in cells pro-
ductively infected with BLV [9]. BLV can integrate into
dispersed sites within the host genome [11] and appears
to be transcriptionally silent in vivo [12]. Indeed, tran-
scription of the BLV genome in fresh tumor cells or in
fresh peripheral blood mononuclear cells (PBMCs) from
infected individuals is almost undetectable by conven-
tional techniques [12,13]. In situ hybridization has
revealed the expression of viral RNA at low levels in
many cells, and at a high level in a few cells in popula-
tions of freshly isolated PBMCs from clinically normal
BLV-infected animals [14]. It appears that BLV provirus
remains integrated in cellular genomes, even in the
absence of detectable BLV antibodies. Therefore, in
addition to the routine diagnosis of BLV infection using
conventional serological techniques such as the immu-
nodiffusion test [15-18] and enzyme-linked immunosor-
bent assay (ELISA) [17-20], diagnostic BLV PCR
techniques that aim to detect the integrated BLV
proviral genome within the host genome are also com-
monly used [17-19,21-23]. However, real-time quantita-
tive PCR for BLV provirus of all known variants has not
been developed, largely due to differences in amplifica-
tion efficiency caused by DNA sequence variations
between clinical samples.
BLV infects cattle worldwide, imposing a severe eco-
nomic impact on the dairy cattle industry [16-20,24-26].
Recent studies on the genetic variability of the BLV env
gene have shown genetic variations among BLV isolates
from different locations worldwide [24,27]. Therefore, in
this study, we used the CoCoMo algorithm to design
degenerate primers addressing BLV diversity and used
these primers to develop a new quantitative real-time
PCR method to measure the proviral load of all BLV
variants. To normalize the viral genomic DNA, the
BLV-CoCoMo-qPCR technique amplifies a single-copy
host gene [bovine leukocyte antigen (BoLA)-DRA gene]
in parallel with the viral genomic DNA. The assay is
specific, sensitive, quantitative and reproducible, and is
able to detect BLV strains from cattle worldwide,
including those for which previous attempts at detection
by nested PCR failed. Interestingly, we succeeded in
confirming that the BLV copy number in PBMC clearly
increased with disease progression.
Results
Principle of absolute quantification for determination of
BLV proviral copy number
To determine the absolute copy number of BLV pro-
virus, we selected the LTR region as a target sequence
for PCR amplification (Figure 1A). In designing the
assay, we took into account the fact that two LTRs will
be detected for each individual BLV genome (see equa-
tion below). To normalize genomic DNA input, the
assay also included a parallel amplification of the single-
copy BoLA-DRA gene (Figure 1B). The number of pro-
viral copies per 100,000 cells is calculated according to
the following equation:
BLV provirus load
BLV provirus copy number diploid cell nu = /m mber 1  cells
BLV LTR copy number 2 BoLA DRAcopy 
×
= () −
00 000 ,
// ( n number 2 1  cells  A /) , × () 00 000
Use of the CoCoMo algorithm to construct a primer set
with the ability to amplify all BLV strains
To amplify all BLV variants, primers targeting the BLV
LTR region were constructed using the modified
CoCoMo algorithm, which was developed to design
PCR primers capable of amplifying multiple strains of
virus. We collected 356 BLV nucleotide sequences from
GenBank (on 30
th April, 2009). From these BLV
sequences, 102 LTR sequences were selected according
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LTR sequences, we selected 85 sequences that were
large enough to determine homologies and assigned
the sequences to major BLV LTR groups based on
homology using a graphical approach with Pajek gra-
phical software (Additional file 2). Fifty two of these
sequences were selected for primer design (Additional
file 3). The target sequences were subjected to a BLV
LTR modified version of the CoCoMo-primer-design
algorithm, which was developed for designing degener-
ate primers to detect multiple strains of virus. Using
these sequences as templates, a total of 72 primer sets
(Figure 2B) with 49 candidate primers (Table 1) were
designed.
Selection of the primer set and probe for amplification of
the BLV LTR region
To determine whether the CoCoMo primer sets ampli-
fied the BLV LTR region, touch-down PCR was per-
formed with 72 candidate primer sets (Figure 2B) using
genomic DNA extracted from BLV-infected BLSC-KU-
17 cells. As shown in Figure 2A, we identified 16 sets of
primers, 1-6, 9, 15-17, 20, 21, 24, 33, 43 and 46, which
successfully amplified the BLV LTR region.
The specificity of the 16 selected primer sets was eval-
uated by melting-curve analysis of amplification using
genomic DNA extracted from BLSC-KU-17 cells or
PBMCs from BLV-free normal cattle Ns118, with
reagent-only as the negative control. Figure 2C shows
Figure 1 The position, length and orientation of primers and probes used in the bovine leukemia virus (BLV)-CoCoMo-qPCR method.
Labeled arrows indicate the orientation and length of each primer. The black filled box indicates the probe annealing position. (A) The proviral
structure of BLV in the BLV cell line FLK-BLV subclone pBLV913, complete genome [DDBJ: EF600696]. It contains two LTR regions at nucleotide
positions 1-531 and 8190-8720. Lowercase labels indicate these LTR regions. The upper number shows the position of the 5’ LTR and the lower
number shows the position of the 3’LTR. Both LTRs include the U3, R and U5 regions. A triplicate 21-bp motif known as the Tax-responsive
element (TRE) is present in the U3 region of the 5’ LTR. The target region for amplification was in the U3 and R region, and the TaqMan probe
for detecting the PCR product was from the R region. (B) The schematic outline of the bovine major histocompatibility complex (BoLA)-DRA
gene (upper) and its cDNA clone MR1 [DDBJ: D37956] (lower). Exons are shown as open boxes. The numbers indicate the numbering of the
nucleotide sequence of MR1. 5’UT, 5’-untranslated region; SP, signal sequence; a1, first domain; a 2, second domain; CP, connecting peptide; TM,
transmembrane domain; CY, cytoplasmic domain; 3’UT, 3-untranslated region. The target regions for amplification and for binding of the TaqMan
probe to detect the PCR product are in exon 4.
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Page 3 of 19Figure 2 Selection of the primer set for amplification of the BLV LTR region. (A) Touch-down PCR was performed using 72 primer sets
with 49 primers designed by the CoCoMo program as shown in Table 1. PCR products were detected by electrophoresis on a 3% agarose gel.
Lanes 1-72, 1-72 primer set ID; +, results positive for PCR product; -, negative results for same. *, designates PCR products that were detected but
for which the amplicon sizes differed from the predicted size. (B) Summary of results shown in (A). Primer set IDs are arranged according to the
degeneracy of the primer set and size of the PCR products. (C) The 4 representative melting curves with 16 primer sets of: BLV-infected BLSC-
KU-17 cells (a), BLV-free normal cattle cells (b), and reagent-only as negative control (c). The specificity of the 16 selected primer sets was
checked by melting curve analysis. Each PCR amplification was followed by gradual product melting at up to 95°C. (D) The optimization of PCR
amplification with primer set ID 15 (CoCoMo 6 and 81). The melting curve of PCR products from BLV-infected BLSC-KU-17 cells (a), the BLV-free
normal cattle Ns118 (b), and reagent-only as negative control (c).
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(CoCoMo) algorithm
Primer ID Sequence Primer annealing position in the BLV LTR sequence
1
3’LTR 5’LTR
1 ACCTGYYGWKAAAYTAATAMAATGC 162-186 8351-8375
2 CYDKYSRGYTARCGGCRCCAGAAGC 192-216 8381-8405
3 GSCCYDKYSRGYTARCGGCRCCAGA 189-213 8378-8402
4 VRRAAWHYMMNMYCYKDAGCTGCTG 132-156 8321-8345
5 KDDWAAHTWAWWMAAWKSCGGCCCT 169-193 8358-8382
6 MNMYCYKDRSYKSYKSAYYTCACCT 141-165 8330-8354
7 YYSVRRAAWHYMMNMYCYKDAGCTG 129-153 8318-8342
8 GCTCCCGAGRCCTTCTGGTCGGCTA 266-290 8455-8479
12 NMYCYKDRSYKSYKSAYYTCACCTG 142-166 8331-8355
17 SGKYCYGAGYYYKCTTGCTCCCGAG 250-274 8439-8463
20 YSGKYCYGAGYYYKCTTGCTCCCGA 249-273 8438-8462
22 HVVRRWMHHYMMNMYSHKNWGCTGC 130-154 8319-8343
30 YYYSGKYCYGAGYYYKCTTGCTCCC 247-271 8436-8460
32 SGSMVCMRRARSBRYTCTYYTCCTG 204-228 8393-8417
33 YYYYSGKYCYGAGYYYKCTTGCTCC 246-270 8435-8459
34 VCMRRARSBRYTCTYYTCCTGAGAC 208-232 8397-8421
39 GSMVCMRRARSBRYTCTYYTCCTGA 205-229 8394-8418
56 MNMYMYDNVSYKVBBBRYYKCACCT 141-165 8330-8354
58 YSBRRGBYBKYTYKCDSCNGAGACC 253-277 8442-8466
62 BYSBRRGBYBKYTYKCDSCNGAGAC 323-347 8441-8465
63 YYYYBGBYYYSWGHYYBCKYGCTCC 246-270 8587-8611
64 VRDNYHHNHYYYBNRKYYBYTGACC 354-378 8324-8348
65 HVVNVHVNHHVVNVNSNKNWGMYGS 43-67, 68-92, 130-154 8232-56, 8257-81, 8319-43
66 NNHHDHBHRWDMMAHNSMBDSMSYK 124-148, 169-193, 170-194 8313-37, 8358-82, 8359-83
68 BNNVBBHVNVHNYYYBNYHVMYBHS 26-50, 91-115, 247-271 8215-39, 8280-8304, 8436-60
69 NVMNBNNHHVDNHWMHYSMBRMSCT 123-147, 128-152, 211-235 8312-36, 8317-41, 8400-24
70 NNNBBHVBVNNHNBBRHYYBTCTCC 202-226, 360-384, 375-399 8391-8415, 8549-73, 8564-88
73 TGGTCTCHGCYGAGARCCNCCCTCC 325-349 8514-8538
76 GCCGACCAGAAGGYCTCGGGAGCAA 264-288 8453-8477
80 SSSRKKBVVRVSCMRRMSSCCTTGG 421-445 8610-8634
81 TACCTGMCSSCTKSCGGATAGCCGA 284-308 8473-8497
83 KKBVVRVSCMRRMSSCCTTGGAGCG 417-441 8606-8630
85 GMCSSCTKSCGGATAGCCGACCAGA 279-303 8468-8492
90 CCTGMCSSCTKSCGGATAGCCGACC 282-306 8471-8495
95 YYYMMVMVBBKKNBTDKCCTTACCT 304-328 8493-8517
97 RMVVRDVBVVGVBDSMVRSCCWKRS 421-445, 429-453 8610-8634, 8618-8642
103 VMVVVDRVNVSSVDKVMRVSCYWGR 421-445, 430-454 8610-8634, 8619-8643
108 YYMMVMVBBKKNBTDKCCTTACCTG 303-327 8492-8516,
112 VVVRRNBSVRRBBVVRVSCCMKWSG 421-445, 428-452 8610-8634, 8617-8641
130 NKNVVRVSCVVVVVVVSWKRGAGCG 417-441, 484-508 8606-8630, 8673-8697
135 NNVVNDRVNVBNNDKNNNNNBHNND 4-28, 90-114, 105-129, etc 8610-8634, 8619-8643, etc
136 BHYYYBNSSSVHKVSRGRKMGCCGA 284-308, 495-519 8473-8497, 8684-8708
137 DRRRSYHVSVRDRSTCDSDRCCGAG 247-271, 336-360 8436-8460, 8525-8549
138 WWVVDSHYSSVKKSSKSWYWGCCGA 284-308, 337-861 8473-8497, 8526-8550
140 NHNNNBBBSSVVTRGWSKSHGCCGA 337-361, 495-519 8526-8550, 8684-8708
141 NRRRVBHVVVRDRSYYNSDRCCGAG 247-271, 336-360 8436-8460, 8525-8549
142 NHNNNBBBSSVNYDSWSBBNGCCGA 337-361, 495-519 8526-8550, 8684-8708
143 VMVVVNDNNVSSVDDVMVVVCYWGR 279-303, 421-445, 430-454 8468-8492, 8610-34, 8619-43
144 VVVRRNNVVRDBBVVVVBSSMKWSG 378-402, 421-445, 428-452 8567-8591, 8610-34, 8617-41
1Numbers indicate the position in the nucleotide sequence of the FLK-BLV subclone pBLV913 [DDBJ: EF600696].
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a single PCR product with a single melting temperature
exhibited a single peak, while amplicons consisting of
two or more products exhibited multiple peaks. The
amplicon generated using primer set ID15 of CoCoMo
6 and CoCoMo 81 had a single melting temperature
using BLSC-KU-17 genomic DNA. Using these primers,
no amplicons were generated using genomic DNA from
PBMCs in BLV-free normal cattle Ns118 or using the
reagent-only control. In contrast, other primer sets,
such as ID3, ID16 and ID17 generated amplicons from
genomic DNA extracted from PBMCs from BLV-free
normal cattle Ns118 or in reagent only, as well as from
genomic DNA extracted from BLSC-KU-17 cells. There-
fore, we proceeded to optimize the amplification condi-
tions using primer sets CoCoMo 6 and CoCoMo 81,
which were the best pair for the detection of the BLV
LTR region (Figure 2D). Under these optimized condi-
tions, amplification melting-curve analysis using geno-
mic DNAs extracted from 56 BLV-infected cattle and
from 3 BLV-free normal cattle showed the same pat-
terns as seen in BLSC-KU-17 cells and BLV-free normal
cattle Ns118 (data not shown).
The internal BLV TaqMan probe was constructed
from a region of low variability located between posi-
tions corresponding to the CoCoMo 6 and CoCoMo 81
primers in the LTR regions of the BLV genome (Figure
1), and was labeled with carboxyfluorescein (FAM) dye,
non-fluorescent quencher (NFQ) and minor groove bin-
der (MGB) probe for enhancing the probe melting tem-
perature. The probe was designated as FAM-BLV.
Alignments of the sequences corresponding to the pri-
mer and probe regions from the 52 BLV LTR sequences
taken from GenBank are shown in Figure 3. Based on
this comparison, out of the 52 sequences, 8 individual
sequences corresponding to CoCoMo 6 primer and 4
individual sequences for CoCoMo 81 primer could be
arranged. The alignment demonstrated that although
the sequences in the probe region were sufficiently con-
served to allow alignment of the BLV variants, the
sequences corresponding to the CoCoMo 6 and
CoCoMo 81 primers exhibited a low degree of
similarity.
Construction of the primer set and probe for
quantification of the BoLA-DRA gene
For normalization of the genomic DNA used as the PCR
template, we designed primers and a probe for quantifi-
cation of the BoLA-DRA gene (Figure 1). We obtained
sequences from an MR1 cDNA clone [DDBJ: No.
D37956] and selected the exon 4 region of the BoLA-
DRA gene as the target for amplification. We designed
the amplification primer set DRA643 and DRA734 and
the internal BoLA-DRA TaqMan probe using the Primer
Figure 3 Sequence alignment of annealing positions of the
CoCoMo 6 primer (A), FAM-BLV-MGB probe (B) and CoCoMo
81 primer (C) in the 52 BLV LTR sequences. The sequence
alignment used 52 sequences from GenBank that were integrated
into a total of 11 sequences, including 8 individual sequences for
the CoCoMo 6 primer and 4 individual sequences for the
CoCoMo81 primer. Accession numbers for the representative
sequences are indicated in the left column. Numbers indicate the
numbering of the nucleotide sequence of the FLK-BLV subclone
pBLV913 [DDBJ: EF600696]. The upper number shows the position
of the 5’ LTR and the lower number shows the position of the 3’
LTR.
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probe was labeled with VIC dye, NFQ and an MGB
probe for enhancing the probe melting temperature, and
was designated as VIC-DRA.
Quantification of plasmid DNA copy number to create
standard curves for absolute quantitative PCR
To obtain standards for quantification of BLV proviral
DNA and cellular DNA, pBLV-LTR/SK, which includes
a full-length LTR of BLV, and pBoLA-DRA/SK, which
includes a full-length bovine DRA gene, were prepared
at 103.1 ng/μl (pBLV-LTR
conc) and 125.0 ng/μl (pBoLA-
DRA
conc), respectively. The copy numbers of these plas-
mids were calculated by the serial dilution method: each
plasmid was diluted 10-fold, and the target DNA was
detected by nested PCR. For example, at a 10
-11 dilution
of pBLV-LTR
conc, PCR amplification failed to detect any
PCR product, including the BLV LTR. The PCR reaction
was then replicated 10 times at the 10
-11 dilution, and
the success rate was found to be 5/10. This result
showed that 5 of 10 PCR solutions did not contain the
LTR gene, expressed in equation form as: f (x = 0) = 5/
10. Finally, the average copy number of the target gene
(l) was calculated as -loge (5/10) = 0.231 corresponding
to a copy number for pBLV-LTR
conc of 2.31 × 10
10/μl.
Using the same strategy, the copy number of pBoLA-
DRA
conc was determined to be 2.54 × 10
10/μl. For con-
firmation of the reliability of estimated copy numbers,
we also calculated draft copy numbers from the DNA
weight and obtained a very similar result (2.35 × 10
10
for pBLV-LTR
conc, and 2.85 × 10
10 for pBoLA-DRA
conc).
Final procedure for the optimization of BLV-CoCoMo-
qPCR
To construct the standard curve, the following dilutions
of pBLV-LTR
conc and pBoLA-DRA
conc were created: 0.1
copy/μl, 1 copy/μl, 1,000 copies/μl and 1,000,000 copies/
μl. A 168-bp amplicon from the BLV LTR region was
amplified in a total volume of 20 μlo f1×T a q M a n
Gene Expression Master Mix containing 500 nM
CoCoMo 6 primer, 50 nM CoCoMo 81 primer, 150 nM
FAM-BLV probe (5’-FAM-CTCAGCTCTCGGTCC-
NFQ-MGB-3’), and 30 ng of template DNA. In addition,
a 57-bp amplicon of the BoLA-DRA region was ampli-
fied in a total volume of 20 μl of 1 × TaqMan Gene
Expression Master Mix containing 50 nM of DRA643
primer (5’-CCCAGAGACCACAGAGAATGC-3’), 50
nM of DRA734 primer (5’-CCCACCAGAGCCA-
CAATCA-3’), 150 nM of VIC-DRA probe (5’-VIC-
TGTGTGCCCTGGGC-NFQ-MGB 3’), and 30 ng of
template DNA. PCR amplification was performed with
the ABI 7500 Fast Real-time PCR system according to
the following program: Uracil-DNA Glycosylase (UDG)
enzyme activation at 50°C for 2 min followed by
AmpliTaq Gold Ultra Pure (UP) enzyme activation at
95°C for 10 min, and then 85 cycles of 15 sec at 95°C
and 1 min at 60°C. Copy numbers obtained for the BLV
LTR and BoLA-DRA were used to calculate BLV pro-
viral load per 100,000 cells, as shown in Equation (A).
Reproducibility of BLV-CoCoMo-qPCR
The intra- and inter-assay reproducibility of BLV-
CoCoMo-qPCR for determination of BLV proviral copy
number was evaluated using aliquots of genomic DNA
extracted from blood samples from seven BLV-infected
cattle (Table 2). For determination of intra-assay repro-
ducibility, we examined triplicate PCR amplifications
from each sample, with the assay being repeated three
times. A total of 21 examinations were performed, and
the intra-assay coefficient of variance (CV) ranged from
0% to 20.5% (mean 8.6%). For determination of inter-
assay reproducibility, we performed three independent
experiments for each sample. The values for the inter-
assay CV for BLV proviral copy number per 100,000
cells ranged from 5.5% to 19.8% (mean 12.7%). These
results clearly demonstrated that this assay has good
intra- and inter-assay reproducibility.
Evaluation of the specificity of BLV-CoCoMo-qPCR primers
using various retroviruses
The specificity of BLV-CoCoMo-qPCR primers was
tested using various retroviral molecular clones, includ-
ing BLV, HTLV-1, human immunodeficiency virus type
1 (HIV-1), simian immunodeficiency virus (SIV), mouse
mammary tumor virus (MMTV), Molony murine leuke-
mia virus (M-MLV), and a range of plasmids including
pUC18, pUC19, pBR322, and pBluescript II SK (+). For
r e a l - t i m eP C R ,C o C o M o6a n dC o C o M o8 1p r i m e r s
were used with 0.3 ng of each plasmid, and the products
were analyzed by 3% agarose-gel electrophoresis. A sin-
gle PCR product, 168-bp in length, was observed only
for the BLV infectious molecular clone (Figure 4A), with
a copy number of 7.9 × 10
10/μg±4 . 3×1 0
10/μg( F i g u r e
4B). No amplicons were detected for any of the other
plasmids. These results strongly indicate that BLV-
CoCoMo-qPCR primers specifically amplify the BLV
LTR without amplifying the LTRs of other retroviruses.
Evaluation of the sensitivity of BLV-CoCoMo-qPCR
compared with nested PCR
To determine the sensitivity of BLV-CoCoMo-qPCR, 20
solutions, each containing 0.7 copies of pBLV-LTR/SK,
were amplified by nested PCR and real-time PCR using
the CoCoMo 6 and CoCoMo 81 primer set (Figure 5).
Three out of ten nested PCR amplifications were posi-
tive, and the copy number was estimated to be 0.36. For
real-time PCR using the CoCoMo 6 and CoCoMo 81
primer set, five out of ten PCR amplifications were
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This result showed that the sensitivity of BLV-CoCoMo-
qPCR was 1.9-fold greater than that of nested PCR.
Comparison of BLV-CoCoMo-qPCR and Serial dilution
nested PCR
The serial dilution method is effective for quantifying
the copy number of a target gene. The BLV proviral
copy number per 1 μg of genomic DNA was calculated
for five BLV-infected cattle by serial dilution-nested
P C Ra n dr e a l - t i m eP C Rw i t ht h eC o C o M o6a n d
CoCoMo 81 primer set (Figure 6A). The BLV proviral
copy number obtained by both methods was confirmed
by regression analysis: the square of the correlation
coefficient (R
2) was 0.8806 (Figure 6B), indicating that
t h ec o p yn u m b e ro b t a i n e db yr e a l - t i m eP C Rw i t ht h e
CoCoMo primers correlated with that obtained by serial
dilution-nested PCR. Thus, it appears that real-time
PCR with the CoCoMo 6 and CoCoMo 81 primer set
can be used to obtain the copy number of BLV provirus
from a clinical sample.
Correlation of BLV-CoCoMo-qPCR and syncytium
formation assay
To test whether the BLV proviral copy number corre-
lates with the capacity for infection with BLV, BLV-
CoCoMo-qPCR and a syncytium formation assay were
conducted on samples from five BLV-infected cattle.
We evaluated the capacity for transmission of BLV by
coculturing 1 × 10
5 PBMCs from five BLV-infected
cattle with inducer CC81 cells for three days and com-
paring proviral copy numbers with 1 × 10
5 cells from
the same cattle (Figure 7A). Proviral copy numbers
ranged from 113 to 63,908 copies per 10
5 cells, and
syncytium numbers ranged from 36 to 12,737 per 10
5
PBMCs. Regression analysis for these samples revealed
that the level of provirus load positively correlated
with the number of syncytia (R
2 = 0.9658), as shown
in Figure 7B.
BLV provirus detection in cattle from different geographic
locations by BLV-CoCoMo-qPCR and nested PCR
BLV-CoCoMo-qPCR has the potential ability to detect
various BLV strains, both known and unknown, because
degenerate primers are capable of detecting highly
degenerate sequences. In the experiments described
above, we found that the sensitivity of BLV-CoCoMo-
qPCR was greater than that of nested PCR. Therefore,
we examined whether BLV-CoCoMo-qPCR can detect
BLV provirus in cattle from different geographic loca-
tions worldwide. We tested 54 cattle from one farm in
Japan, 15 cattle from two farms in Peru, 60 cattle from
four farms in Bolivia, 32 cattle from three farms in
Chile and 5 cattle from one farm in the U.S.A., and
compared the results obtained by BLV-CoCoMo-qPCR
with the results obtained by nested PCR (Table 3). The
amplification of BLV LTR by the two methods divided
the 166 cattle into three groups. The first group of cattle
(n = 107) was positive for BLV LTR by both methods
(50 in Japan, 7 in Peru, 27 in Bolivia, 18 in Chile, and 5
in U. S. A.). The second group of cattle (n = 50) was
negative for BLV LTR by both methods (2 in Japan, 7 in
Peru, 28 in Bolivia, and 13 in Chile). The third group of
cattle (n = 9) was positive by BLV-CoCoMo-qPCR but
negative by nested PCR (2 in Japan, 1 in Peru, 5 in Boli-
via, and 1 in Chile). Interestingly, none of the cattle
were negative by BLV-CoCoMo-qPCR but positive by
nested PCR. Thus, the nested PCR and BLV-CoCoMo-
qPCR methods gave the same result for 94.6% of the
cattle tested, but for 5.4% of the cattle, only the BLV-
CoCoMo-qPCR was able to detect BLV provirus. These
results clearly showed that the sensitivity of BLV-
CoCoMo-qPCR was higher than that of nested PCR.
As shown in Table 3, we detected several samples that
were positive by BLV-CoCoMo-qPCR, but negative by
nested PCR. To confirm that these samples were
infected with BLV, and to investigate why these samples
were not detected by nested PCR, we sequenced the
LTR region of nine samples from this group: YA40,
Table 2 Intra- and inter-assay reproducibility of BLV-CoCoMo-qPCR
No. Proviral load
1 Intra-assay
2 Inter-assay
3
Exp.1 Exp 2 Exp 3 Exp.1 Exp.2 Exp.3 Exp.1~3
Ns105 1998 ± 385 2107 ± 296 1581 ± 150 17.9 14.1 9.5 14.6
Ns209 3951 ± 691 3751 ± 529 3049 ± 150 17.5 14.1 4.9 13.2
Ns126 20388 ± 222 23484 ± 1854 28375 ± 1381 1.1 7.9 4.9 16.7
Ns226 30155 ± 6184 27247 ± 1454 34954 ± 3021 20.5 5.3 8.6 12.6
Ns120 57236 ± 6127 59375 ± 3195 53225 ± 2514 10.7 5.4 4.7 5.5
Ns107 90947 ± 0 73002 ± 3228 61388 ± 4779 0.0 4.4 7.8 19.8
Ns112 87377 ± 7434 94934 ± 5891 84667 ±5763 8.5 6.2 6.8 6.0
1Values represent the mean ± standard deviation (SD) of BLV proviral copy numbers in 10
5 cells from triplicate PCR amplifications from each sample.
2Intra-CV: Coefficient of variation between each sample.
3Inter-CV: Coefficient of variation between each experiment.
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Page 8 of 19MO85, YA35, YA56 and ME10 from Bolivia, HY2 from
Peru, C336 from Chile, and Ns27 and Ns29 from Japan.
We were able to detect BLV LTR sequences in all nine
s a m p l e s( F i g u r e8 ) ,t h u sc o n f i rming the high specificity
of BLV-CoCoMo-qPCR. In two of the nine samples, we
identified mismatch sequences at the annealing region
for the primer BLTR453, which was used for amplifica-
tion of the LTR in nested PCR. This is a possible expla-
nation for why the nested PCR failed to detect the BLV
provirus.
Correlation analysis of disease progression and BLV
proviral load
To characterize differences in BLV proviral load in the
early and late stages of disease, we calculated BLV pro-
viral copy numbers for 268 BLV-infected cattle in differ-
ent stages of progression of EBL. We measured proviral
load in 163 BLV-positive, healthy cattle, 16 BLV-infected
cattle with PL, 89 BLV-infected cattle with lymphoma,
and 117 BLV-free normal cattle by BLV-CoCoMo-qPCR
(Figure 9). The proviral loads were significantly
Figure 4 Evaluation of the specificity of the BLV-CoCoMo-qPCR primers. (A) Real-time PCR using the CoCoMo 6 and CoCoMo 81 primers
from the BLV-CoCoMo-qPCR was performed using 0.3 ng of the following infectious molecular clones: BLV (pBLV-IF, lane 2); HTLV-1 (pK30, lane
3); HIV-1 (pNL4-3, lane 4); SIV (pSIVmac239/WT, lane 5); MMTV (hybrid MMTV, lane 6); M-MLV (pL-4, lane 7); and the plasmids pUC18 (lane 8),
pUC19 (lane 9), pBR322 (lane 10), and pBluescript SK(+) (lane 11). PCR products were subjected to 3% agarose gel electrophoresis. Lane 1, DNA
marker F × 174-Hae III digest. A PCR product 168 bp in length is indicated by an arrow. (B) The number of BLV provirus copies in 1 μg of DNA
from each DNA sample is indicated by lowercase. Values represent the mean ± standard deviation (SD) of the results of three independent
experiments.
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Page 9 of 19Figure 5 Comparison of the sensitivity of BLV-CoCoMo-qPCR and nested PCR. Ten samples containing 0.7 copies of pBLV-LTR/SK were
amplified by nested PCR (A) and real-time PCR with the CoCoMo 6 and CoCoMo 81 primer set (B). The 168-bp band was used to detect BLV
LTR amplicons (A). Carboxy-X-rhodamine (ROX) intensities were used for corrections of tube differences, and carboxyfluorescein (FAM) intensities
were used to detect BLV LTR amplicons (B).
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Page 10 of 19increased at the PL stage compared with the aleukemic
stage (p = 0.0159) and were further increased at the
lymphoma stage (p = 0.0052). No BLV was detected in
t h e1 1 7B L V - f r e en o r m a lc a t t l e .T h u s ,w ew e r ea b l et o
demonstrate that BLV proviral copy number increased
with increasing severity of disease.
Discussion
In this study, we describe the successful development of
a highly specific, accurate, and sensitive method for the
quantification of BLV proviral load from infected
animals.
The BLV-CoCoMo-qPCR system is able to detect var-
ious BLV strains from a broad geographical origin,
including Japan, Peru, Bolivia, Chile and the U.S.A.
Although early studies on genetic variability of the BLV
env gene identified very little variation among isolates
[28], recent studies based on restriction fragment length
polymorphism analysis and on analysis of the full-length
BLV env gene have revealed at least seven different BLV
genotypes in circulation worldwide [24,27,29]. This
novel classification suggests that BLV divergence has
increased worldwide. From a total of 356 BLV sequences
in GenBank, we were able to obtain 52 distinct BLV
LTR nucleotide sequences. This indicates that many
BLV variants exist, and our results suggest that detec-
tion of all of these variants is possible using BLV-
CoCoMo-qPCR. Thus, we have clearly demonstrated
that the CoCoMo algorithm is a useful tool for design-
ing degenerate primers corresponding to multiple BLV
variants. In fact, Tong et al. [30] indicated that semi-
nested or nested PCR assays with consensus-degenerate
hybrid oligonucleotide primers for Paramyxoviridae
could be developed to be either highly specific or more
broadly inclusive, enabling targeting at the subfamily or
genus level. Using this type of approach, there is a risk
Figure 6 Correlation between proviral load calculated by BLV-CoCoMo-qPCR and serial dilution nested PCR.( A )B L Vp r o v i r a lc o p y
numbers for 1 μg of genomic DNA from 6 BLV-infected cattle were determined by BLV-CoCoMo-qPCR and serial dilution-nested PCR. For serial
dilution-nested PCR, the 6 genomic DNAs were analyzed by serial tenfold dilution and subjected to nested PCR for detection of the BLV LTR
gene. Nested PCR reactions were repeated 10 times and proviral load was calculated according to a Poisson distribution model as shown in
Methods. Values represent the mean ± standard deviation (SD) of results from four independent experiments. (B) Scatter chart is indicated the
correlation between BLV copy numbers which were determined by BLV-CoCoMo-qPCR and by serial dilution-nested PCR.
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Page 11 of 19Figure 7 Correlation between proviral load calculated by BLV-CoCoMo-qPCR and syncytium formation. (A) Using BLV-CoCoMo-qPCR, the
proviral loads from five BLV-infected cattle were calculated and shown as provirus copy number per 1 × 10
5 cells. A syncytium formation assay
using CC81 indicator cells was used to count the number of syncytia per 1 × 10
5 peripheral blood mononuclear cells (PBMCs) from five BLV-
infected cattle. Values represent the mean ± standard deviation (SD) of results from three samples. (B) Scatter chart is indicated the correlation
between BLV copy numbers which were determined by BLV-CoCoMo-qPCR and the number of syncytia.
Table 3 Comparison of BLV detection by BLV-CoCoMo-qPCR and nested PCR in cattle from Japan, Peru, Bolivia, Chile
and the U.S.A.
Results of BLV detection by BLV-CoCoMo-qPCR/nested PCR
Country +/+
1 -/- +/- -/+
n
2 % n % n % n % Total number
Japan A 50 92.6 2 3.7 2 3.7 0 0 54
Peru A 7 77.8 2 22.2 0 0 0 0 9
B 0 0 5 83.3 1 16.7 0 0 6
Bolivia A 2 40.0 2 40.0 1 20.0 0 0 5
B 4 66.7 2 33.3 0 0 0 0 6
C 5 35.7 8 57.1 1 7.1 0 0 14
D 16 45.7 16 45.7 3 8.6 0 0 35
Chile A 11 68.8 4 25.0 1 6.2 0 0 16
B 0 0 6 100.0 0 0 0 0 6
C 7 70.0 3 30.0 0 0 0 0 10
USA A 5 100.0 0 0 0 0 0 0 5
1+, positive for detection of BLV; -, negative for detection of BLV.
2n, number of samples with identical decisions based on two methods.
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Page 12 of 19Figure 8 Alignment of BLV LTR nucleotide sequences in samples that were positive by BLV-CoCoMo-qPCR but negative by nested
PCR. BLV LTR sequences from 9 BLV-infected cattle were amplified by PCR using three primer pairs, BLTR56F and CoCoMo81, BLTR134F and
BLTR544R, and CoCoMo6 and CoCoMo81, followed by sequencing of the PCR products. Closed arrows indicate the position, orientation and
length of these primers. The LTR sequences at nucleotide positions 74-283 and 154-526 from YA40, MO85 and YA35 were amplified using two
primer pairs BLTR56F and CoCoMo81, and BLTR134F and BLTR544R, respectively. The LTR sequence at nucleotide positions 74-283 from YA56
was amplified by primer pair BLTR56F and CoCoMo81. The LTR sequences at nucleotide positions 166-283 from HY2, Ns27, ME10 and C336 were
amplified by the primer pair CoCoMo6 and CoCoMo81. The LTR sequence at nucleotide positions 154-526 from Ns29 was amplified by primer
pair BLTR134F and BLTR544R. Open arrows indicate the position, orientation and length of first primer pair, BLTR-YR and BLTRR, and the second
primer pair, BLTR256 and BLTR453, for nested PCR. The numbers at the top of the sequences indicate the terminal bases according to the
nucleotide sequence of the FLK-BLV subclone pBLV913 [DDBJ: EF600696]. Conserved sequences are indicated by a dot (.), deletions are indicated
by a hyphen (-). A lack of sequence information is indicated by the symbol (*).
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Page 13 of 19that the degeneracy of the CoCoMo primers could be
too high, thereby reducing the concentration of primer
specific to the target sequence and decreasing the assay’s
sensitivity. This issue did not arise in our study since
BLV-CoCoMo-qPCR was highly sensitive and gave
superior results to nested PCR amplification (Figure 6).
In addition, the BLV-CoCoMo-qPCR system was very
effective in detecting virus in BLV-infected cattle from a
r a n g eo fg e o g r a p h i cl o c a t i o n s( T a b l e3 ) .T h eT a q M a n
probe was used to improve sensitivity and specificity
and acts to counter any drawbacks associated with high
degeneracy. It is important to note that the sequence of
the BLV TaqMan probe, located between positions cor-
responding to the CoCoMo 6 and CoCoMo 81 primers,
was completely conserved among the 52 BLV variants.
The ELISA and immunodiffusion screening methods for
BLV in cattle are also highly sensitive but they act by
detecting antibodies against BLV, in contrast to the
direct detection of integrated provirus by PCR [17]. The
ELISA and immunodiffusion methods suffer from a high
rate of false positives, and they are also ineffective in
determining whether calves are infected since circulating
maternal antibodies from BLV-infected dams can inter-
fere with the assay. Reliable detection of BLV-infection
in cattle therefore requires a high-sensitivity method for
the detection of provirus. To this end, we developed
BLV-CoCoMo-qPCR.
Several approaches were used to confirm the high spe-
cificity of BLV quantification using CoCoMo primers.
First, the CoCoMo 6 and CoCoMo 81 primers yielded a
single peak by melting curve analysis in cells infected
w i t hB L V ,b u td i dn o ta m p l i f yap r o d u c ti nu n i n f e c t e d
cells or in the reagent-only negative control. Second,
PCR amplification was detected in BLV-positive cattle,
but was negative in all 120 BLV-negative cattle tested.
Third, infectious molecular clones including several
non-BLV retroviral LTRs were not amplified by our
system.
A previous study [31] reported a method to quantify
BLV provirus using real-time PCR. This method tar-
geted the BLV env and pol genes, which are present at
only one copy per provirus, and the primer annealing
regions were potentially susceptible to mutation. The
BLV LTR target of BLV-CoCoMo-qPCR is present at
two copies per provirus, which contributes to the
improved sensitivity of our assay. Indeed, using the
quantitative PCR method described by Lew et al. [31],
we could not detect provirus at less than 18 copies/10
5
cells, a concentration that was readily detectable by
BLV-CoCoMo-qPCR (data not shown). Our method
also has the advantage that the use of degenerate pri-
mers allows for the detection of BLV sequence variants,
including those that arise from mutations.
The BLV-CoCoMo-qPCR method was also accurate.
The provirus copy number obtained using real-time
PCR with CoCoMo primers correlated closely with the
result from serial dilution nested PCR. Because we
aimed to use BLV-CoCoMo-qPCR to quantify cell-
associated BLV provirus, we performed a parallel quan-
titation of the single-copy cellular gene BoLA-DRA. This
measurement allowed adjustment for variations in
amplification efficiency between samples. Using this
strategy, we observed sufficient intra- and inter-assay
reproducibility for the diagnosis of infected animals. The
assay CV range was 0.0% to 20.5%, which was markedly
better than that reported for quantification of HTLV-1
proviral load (8.2% to 31.4% [32] or 49% to 55% [33]).
The high reproducibility of our assay enabled its use for
the quantitation of proviral load during disease progres-
sion. The accuracy of BLV-CoCoMo-qPCR was also
confirmed by sequencing analysis. We selected nine
s a m p l e si nw h i c hB L Vp r o v i r u sc o u l db ed e t e c t e db y
BLV-CoCoMo-qPCR, but not by nested PCR, and
sequenced the amplicons. Using this strategy, we con-
firmed that the nine samples were infected by BLV, and
this highlights the ability of the BLV-CoCoMo-qPCR
Figure 9 I n c r e a s e dp r o v i r a ll o a dc o r r e l a t e sw i t hd i s e a s e
progression in BLV-induced enzootic bovine leukosis (EBL). The
proviral load was calculated for 385 cattle by BLV-CoCoMo-qPCR.
The cattle were classified into four disease stages according to
diagnosis based on previously established criteria [41], the genomic
integration of BLV, and the detection of antibodies to BLV: 117 BLV-
negative cattle (BLV-); 163 BLV-infected cattle that were clinically
and hematologically normal (aleukemic); 16 clinically normal, BLV-
infected cattle with persistent lymphocytosis (PL); and 89 BLV-
infected cattle with lymphoma. The circles/dots indicate the average
proviral load detected in each stage, and the bar indicates the
standard error. P-values were calculated by pairwise t-test using R
version 2.10.1 (The R Foundation for Statistical Computing).
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Page 14 of 19method to detect provirus in samples that were negative
by nested PCR. In two of the nine samples, sequence
mismatches were detected at the annealing region for
the nested PCR primers, thereby suggesting an explana-
tion for the failure of nested PCR to detect BLV in
these samples.
The syncytia assay is a common strategy for detecting
viable BLV virus particles [34]. However, this method
requires cell culture, is time consuming and often diffi-
cult, and also has low sensitivity. We tested whether the
proviral copy number obtained with our assay correlated
with the syncytium formation assay, since this would
suggest that our assay could be used for diagnosis at the
BLV infection stage. Syncytia formation correlated
strongly with a proviral load of over 10,000 copies/10
5
cells, as calculated by BLV-CoCoMo-qPCR. In BLV-
infected cattle with a low proviral load detected by
BLV-CoCoMo-qPCR, syncytia formation could hardly
be detected. Thus, BLV-CoCoMo-qPCR appears to be
capable of correctly determining the level of BLV infec-
tion in animals with low viral loads.
T h ep r e - l e u k e m i cp h a s eo fB L Vi n f e c t i o n ,c a l l e da s
PL, is characterized by the expansion of infected sur-
face immunoglobulin M-positive B-cells with proviral
insertion at multiple sites. On the other hand, a unique
integration site is characteristic of malignant of malig-
nant B-cells found in BLV-infected individuals after
the onset of overt leukemia/lymphoma [13,23,35].
According to this model, proviral load should increase
during disease progression but this has not been for-
mally demonstrated. Using BLV-CoCoMo-qPCR, we
were able to detect an increase in proviral load during
disease progression. This result strongly suggests that
proviral load may be an excellent indicator for moni-
toring the progression of disease, but may also be use-
ful for implementing segregation programs to
minimize BLV transmission. Previous experiments also
identified host factors or genetic backgrounds that cor-
relate with disease progression. For example, tumor-
associated c143 antigens have been identified that are
serine phosphorylated specifically in cattle with EBL,
and genetic polymorphisms in cancer-associated genes
such as p53 and tumor necrosis factor (TNF) have also
been linked with EBL [35-41]. Proviral load may also
b eav a l u a b l em e a s u r ef o ri d e n t i f y i n gm a r k e r st h a t
i n f l u e n c ep r o g r e s s i o nt ot h el y m p h o m as t a g e .O u r
assay may be valuable for estimating the effectiveness
of vaccination and may also be capable of detecting
changes in proviral load in BLV-infected cattle with
the TNF and BoLA alleles that have previously been
associated with resistance or susceptibility to BLV-
induced lymphoma. Finally, since our assay detected all
BLV variants, the CoCoMo algorithm appears to be a
useful tool for designing degenerate primers for the
quantification of proviral loads of other retroviruses,
including HTLV and HIV-1.
Conclusions
Using CoCoMo primers, we have developed a new
quantitative real-time PCR method to measure the pro-
viral load of known and novel BLV variants. Our
method is highly specific, sensitive, quantitative and
reproducible for detection of the BLV LTR region in
infected animals. The method was effective in detecting
BLV in cattle from a range of geographical locations,
and detected BLV in a broader range of samples than
the previously developed nested PCR. Finally, we have
shown for the first time that the proviral load correlates
well with the stage of disease progression.
Methods
Clinical samples, cell lines and DNA extraction
Blood samples were obtained from 117 healthy cattle
with negative BLV serology, 163 BLV-infected cattle
that were clinically and hematologically normal, 16 clini-
cally normal BLV-infected cattle with PL, and 89
BLV-infected cattle with EBL. These cattle were all
maintained in Japan. A further 116 cattle that were
maintained in Bolivia, Peru, Chile and the U.S.A were
included in the study. BLV-infected cattle were classified
according to previously established criteria [42] and the
genomic integrations of the BLV provirus. PBMCs were
separated from blood by the method of Miyasaka and
Trnka [43].
The BLV-infected B lymphoma cell line BLSC-KU-17
[44] was maintained in Dulbecco’s modified Eagle’s
medium (Life Technologies Japan, Tokyo, Japan) supple-
mented with 10% heat-inactivated fetal calf serum (FCS)
(Sigma Aldrich Chemie Gmbh, Steinem, Germany),
penicillin and streptomycin. CC81, a cat cell line trans-
formed by mouse sarcoma virus, was maintained in
RPMI 1640 medium (Sigma-Aldrich Co. Ltd., Ayrshire,
UK) supplemented with 10% heat-inactivated FCS, peni-
cillin and streptomycin.
Genomic DNA was extracted from (a) whole blood by
the DNA Wizard Genomic DNA purification Kit (Pro-
mega, Madison, WI), (b) PBMCs by the procedure
described by Hughes et al. [45] and (c) 40 μlo fw h o l e
blood spotted on FTA elute cards (Whatman, Tokyo,
Japan), using standard procedures.
Design of primers and probes
The 52 variants of individual BLV LTR sequences were
selected from 356 BLV sequences in GenBank as shown in
Additional files 1-3. The target sequences were subjected
to a BLV LTR modified version of the CoCoMo-primer-
design algorithm (http://www.geneknot.jp/cocomo; Endoh
D, Mizutani T, Morikawa S Hamaguchi I, Sakai K,
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Page 15 of 19Takizawa K, Osa Y, Asakawa M, Kon Y, Hayashi M,:
CoCoMo-Primers: a web server for designing degenerate
primers for virus research. Submitted), which was devel-
oped for designing degenerate primers to detect multiple
strains of viruses.
To detect specific PCR products, we used the Taq-
Man™probe system (Applied Biosystems, Tokyo, Japan),
with probe sequences designed using Primer Express
software, version 2.0 (Applied Biosystems).
Plasmids
To obtain pBLV-LTR/SK, which included a full-length
LTR from BLV, we used PCR with the primers BLV-
LTR/XhoI (5’-CCCGCTCGAGTGTATGAAAGAT-
CATGCCGA-3’; positions 1 to 20) and BLV-LTRR/
BamHI (5’-CGGGATCCTGTTTGCCGGTCTCTCC-
TGG-3’; positions 511 to 531) and genomic DNA
extracted from BLSC-KU-17 cells as a template. PCR
products were cloned into pBluescript II SK (+) (Strata-
gene, La Jolla, CA). The numbering of nucleotides cor-
responds to positions in the sequences determined by
Derse et al. [46]. To generate pBoLA-DRA/SK, which
includes a full-length bovine DRA gene, we digested
MR1 from the mammalian expression vector pCDM8
[47] with Xba I. The Xba I-Xba I fragment including
the MR1 sequence was then subcloned into pBluescript
II SK (+) (Stratagene). Additional clones used included a
BLV infectious clone, pBLV-IF [34]; a HTLV-1 infec-
tious clone, pK30 [48]; a HIV-1 infectious clone, pNL4-
3 [49]; a SIV infectious clone, SIVmac239/WT [50]; a
hybrid MMTV provirus plasmid [51]; a M-MLV infec-
tious clone, pL-4 [52] and plasmids including pUC18
(Takara Bio Inc., Tokyo, Japan), pUC19 (Takara Bio
Inc.), and pBR322 (Promega).
Calculation of copy number by the serial dilution method
pBLV-LTR/SK and pBoLA-DRA/SK were digested with
Sca I and purified using a Sephadex G-50 column (GE
Healthcare Japan, Tokyo, Japan). The genomic DNA
was digested with Xho I in the presence of 5 mM sper-
midine for 24 h. The samples were diluted to serial ten-
fold dilutions with TE buffer [10 mM Tris-HCl (pH 8.0)
with 1 mM ethylenediamine tetraacetic acid ] on-ice. To
avoid DNA adsorption to the microtubes, super smooth
processed tubes (BM4015 Platinum super polypropylene;
BM bio, Tokyo, Japan) were used for the preparation of
template for the standard curve.
Limiting dilutions were performed for linearized
pBLV-LTR/SK, pBoLA-DRA/SK and genomic DNA.
Detection of the BLV LTR gene and the BoLA-DRA
gene from plasmid DNA was performed by real-time
PCR with the CoCoMo primers 6 and 81, or the primers
DRA643 and DRA734, respectively. The BLV LTR gene
was also detected in genomic DNA using nested PCR.
At the dilution point at which amplification products
were unable to be detected, PCRs were repeated 10
times and the frequency of negative results was calcu-
lated (f(x = 0)). The copy numbers of the target genes
were calculated according to a Poisson distribution
model: l = -loge(f(x = 0)), where l = average copy num-
ber of the target gene.
PCR conditions for candidate CoCoMo primer sets for the
amplification of the BLV LTR
Touch-down PCR amplifications were carried out in a
20 μl volume of 1 × buffer for rTaq DNA Polymerase
(TOYOBO, Tokyo, Japan) containing 1.0 unit rTaq, 0.2
mM dNTPs, 1.0 mM MgCl2, 500 nM of forward and
reverse primers, and 1 μlo f1 : 1 0 0 0d i l u t e dB L VL T R
amplicon, which had been amplified from genomic
DNA by nested PCR. PCR amplification was performed
with a TGRADIENT thermocycler (Biometra, Göttingen,
Germany) according to the following program: an initial
denaturation at 95°C for 10 min, followed by 40 cycles
of 15 s at 95°C, 10 s at 60°C to 52°C (annealing tem-
perature was gradually decreased from 60°C to 52°C, by
0.2°C every three cycles) and 10 s at 72°C. Five μlo f
PCR products was used for 2% agarose gel electrophor-
esis and amplification products were detected by ethi-
dium bromide staining.
Melting curve analysis for evaluating PCR specificity
PCR amplifications took place in a total volume of 20 μl
of 1 × LightCycler FastStart DNA Master SYBR Green I
(Roche Diagnostics GmbH, Basel, Switzerland) contain-
ing 500 nM of each of the CoCoMo primers, 3 mM of
MgCl2, and 30 ng of genomic DNA. PCR amplifications
were performed with a Light Cycler 2.0 (Roche Diagnos-
tics GmbH) according to the following program: an
initial denaturation at 95°C for 10 min, followed by 75
cycles of 15 s at 95°C, 5 s at 65°C, and 9 s at 72°C. The
melting process was monitored by fluorescence of the
DNA-binding SYBR Green I dye for the detection of
double-stranded DNA.
Detection of BLV LTR by nested PCR
The first PCR amplification was done using the primers
BLTRF-YR (5’-TGTATGAAAGATCATGYCGRC-3’
LTR 1-21) and BLTRR (5’- AATTGTTTGCCGGTCT-
CTC-3’ LTR 515-533). The amplifications were carried
out in a total volume of 20 μl of 1 × buffer for rTaq
DNA Polymerase (TOYOBO) containing 250 nM of
BLTRF-YR primer and BLTRR primer, 0.5 units of rTaq
polymerase, 0.2 mM dNTPs, 2.5 mM MgCl2,a n d3 0n g
of template DNA. PCR amplification was performed
with a TGRADIENT thermocycler (Biometra) according
to the following program: an initial denaturation at 94°C
for 2 min, followed by 35 cycles of 30 sec at 94°C,
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min at 72°C.
The second set of PCR amplifications was performed in
a total volume of 20 μl of 1 × buffer for rTaq DNA Poly-
merase (TOYOBO) containing 250 nM of 256 primer and
453 primer (see below), 0.5 units of rTaq polymerase, 0.2
mM of dNTPs, 2.5 mM of MgCl2, and 1 μl of first-round
PCR product. The oligonucleotide sequences used in the
second PCR were 256 (5’-GAGCTCTCTTGCTCCCGAG-
AC-3’, LTR 256-276) and 453 (5’-GAAACAAACGCGG-
GTGCAAGCCAG-3’, LTR 430-454), and have been
described previously [23]. PCR amplification was per-
formed with a TGRADIENT thermocycler (Biometra)
according to the following program: an initial denaturation
at 94°C for 2 min, followed by 35 cycles of 30 s at 94°C, 30
s at 58°C and 30 s at 72°C, and a final cycle of 5 min at 72°
C. Five μl of PCR products was used for 2% agarose gel
electrophoresis and the PCR products were detected by
ethidium bromide staining.
Amplification, Cloning, and DNA sequencing of BLV LTR
regions
To analyze the nucleotide sequence of samples that
were positive by BLV-CoCoMo-qPCR but negative by
nested PCR, genomic DNA from BLV-infected cattle
was subjected to amplification by PCR using Might-
yAmp DNA polymerase Ver.2 (TAKARA), KOD plus
Neo (TOYOBO), and TaqMan Universal Master Mix II
system (AB). BLV LTR specific oligonucleotide primers
BLTR56F (5’-AACGTCAGCTGCCAGAAA-3’), BLTR
134F (5’-AAAATCCACACCCTGAGCTG-3’), CoCo
Mo6, CoCoMo81, and BLTR544R (5’- ACGAGCCCCC
AATTGTTT-3’) were designed by reference to the LTR
regions of BLV proviral sequences. The PCR products
were subcloned into pGEM-T Easy vector (Promega) by
TA cloning and the nucleotide sequence was deter-
mined by cycle sequencing using standard procedures.
Syncytium formation assay
The assay was performed according to a previously
described procedure [15,22]. CC81 cells were grown for
72 h in a 6-cm-diameter dish and incubated with 4 ×
10
5 PBMC from BLV-infected cattle in RPMI 1640 med-
ium. Cells were fixed in May-Grunwald solution for 2
min and stained with Giemsa solution for 15 min. After
washing with water, cells were examined under a light
microscope. Cells containing more than five nuclei were
counted as syncytia.
Statistical analysis
Statistical analysis was conducted using R 2.10.1 statistical
computing software. For multiple testing, a pairwise t test
was used for calculating pairwise comparisons between
group levels with corrections. P-values of less than 0.05
were considered significant. Regression analysis was used to
examine the correlation between the serial dilution method
and the BLV-CoCoMo-qPCR method, and between the
syncytium count and the provirus copy number.
Additional material
Additional file 1: From the BLV sequences, 102 LTR sequences were
selected based on GenBank annotations. We collected whole
nucleotide sequence-data from GenBank (356 data, on 30th April, 2009).
From the BLV sequences, we selected 102 LTR sequences based on
GenBank annotations.
Additional file 2: LTR-network. From the 102 LTR sequences, we
selected 85 sequences that were of sufficient sizes ( > 400 bp) to
determine homologies, and assigned the sequences to major BLV LTR
groups based on homology using a graphical approach with Pajek
graphical software.
Additional file 3: Selection of representative BLV LTR sequences.I n
the 85 LTR sequence data, we classified homologous sequence groups
and selected one sequence each group. Resultantly, 52 sequences, which
were representing sequence repertoire of BLV LTR sequence, were
selected as the target-set for primer-design.
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